• Accueil >
  • Publications >
  • Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy

Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy

1 déc. 2018International Journal of Cancer

DOI : 10.1002/ijc.31842

Auteurs

Laurent Beziaud, Laura Boullerot, Thi Tran, Laura Mansi, Elodie Lauret Marie-Joseph, Patrice Ravel, Ludger Johannes, Jagadeesh Bayry, Eric Tartour, Olivier Adotévi

Membres

LUDGER JOHANNES

Directeur de recherche Inserm